These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11500972)

  • 1. Src homology-2 domain binding assays by scintillation proximity and surface plasmon resonance.
    Mandine E; Gofflo D; Jean-Baptiste V; Sarubbi E; Touyer G; Deprez P; Lesuisse D
    J Mol Recognit; 2001; 14(4):254-60. PubMed ID: 11500972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain.
    Ye G; Ayrapetov M; Nam NH; Sun G; Parang K
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4994-7. PubMed ID: 16169725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains.
    Sonatore LM; Wisniewski D; Frank LJ; Cameron PM; Hermes JD; Marcy AI; Salowe SP
    Anal Biochem; 1996 Sep; 240(2):289-97. PubMed ID: 8811923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity.
    Cousins-Wasti RC; Ingraham RH; Morelock MM; Grygon CA
    Biochemistry; 1996 Dec; 35(51):16746-52. PubMed ID: 8988011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
    Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
    FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
    Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
    ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface plasmon resonance technology.
    Lung FD; Chang CW; Chong MC; Liou CC; Li P; Peach ML; Nicklaus MC; Lou BS; Roller PP
    Biopolymers; 2005; 80(5):628-35. PubMed ID: 15660381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of water in computational and experimental derivation of binding thermodynamics in SH2 domains.
    Geroult S; Virdee S; Waksman G
    Chem Biol Drug Des; 2006 Jan; 67(1):38-45. PubMed ID: 16492147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A repertoire library that allows the selection of synthetic SH2s with altered binding specificities.
    Malabarba MG; Milia E; Faretta M; Zamponi R; Pelicci PG; Di Fiore PP
    Oncogene; 2001 Aug; 20(37):5186-94. PubMed ID: 11526507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance.
    Mandenius CF; Wang R; Aldén A; Bergström G; Thébault S; Lutsch C; Ohlson S
    Anal Chim Acta; 2008 Aug; 623(1):66-75. PubMed ID: 18611459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors.
    Zhou V; Han S; Brinker A; Klock H; Caldwell J; Gu XJ
    Anal Biochem; 2004 Aug; 331(2):349-57. PubMed ID: 15265741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases.
    Nam NH; Lee S; Ye G; Sun G; Parang K
    Bioorg Med Chem; 2004 Nov; 12(22):5753-66. PubMed ID: 15498652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of the mass transport limited interaction between the tyrosine kinase lck SH2 domain and a phosphorylated peptide studied by a new cuvette-based surface plasmon resonance instrument.
    de Mol NJ; Plomp E; Fischer MJ; Ruijtenbeek R
    Anal Biochem; 2000 Mar; 279(1):61-70. PubMed ID: 10683231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.